Nasal Powder Formulation For Treatment Of Hypoglycemia
Patent No. EP3673899 (titled "Nasal Powder Formulation For Treatment Of Hypoglycemia") was filed by Amphastar Pharmaceuticals on Feb 16, 2016. The application was issued on Jun 25, 2025.
Patent Summary
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP3673899
- Application Number
- EP20151167A
- Filing Date
- Feb 16, 2016
- Status
- Granted And Under Opposition
- May 23, 2025
- Publication Date
- Jun 25, 2025
- External Links
- Slate, Register , Google Patents